Angelakis, I., Huggett, C., Gooding, P., Panagioti, M., & Hodkinson, A. (2022). Effectiveness of cognitive–behavioural therapies of varying complexity in reducing depression in adults: systematic review and network meta-analysis. The British Journal of Psychiatry, 221(2), 459–467.
Summary by: Jessica Freij
A major global health problem, depression, affects hundreds of millions of people worldwide. Although cognitive behavioral therapy (CBT) is widely used in treating depression, its structure and delivery vary widely. To examine how different levels of CBT complexity compare in reducing depressive symptoms in adults, Angelakis et al. (2022) conducted a systematic review and network meta-analysis. Specifically, they examined whether increasing CBT complexity produces stronger treatment effects and whether individual and contextual factors affect treatment outcomes.
Three levels of complexity were established by the authors for cognitive behavioral therapy. Core CBT is based on behavioral activation and/or cognitive restructuring. Complex CBT includes one additional therapeutic component alongside these core techniques. Ultra-complex CBT incorporates the core components along with two or more additional strategies, such as relapse prevention and problem solving. Using standardized mean differences (SMDs), the authors compared outcomes across trials using different depression scales, including the Beck Depression Inventory (BDI), among others.
The review included 107 randomized controlled trials with 15,248 participants, ranging in age from young adulthood to older adulthood, with an average age of approximately 41. Both clinically diagnosed patients and those identified through validated self-report measures such as the BDI were included in the study. Among the studies reporting comorbidities, anxiety disorders and chronic physical illnesses were common. CBT was delivered individually, in groups, and in online formats, and treatment duration and session frequency varied widely. The variability in treatment duration and frequency increased real-world applicability but also led to considerable heterogeneity. To compare multiple treatments simultaneously, the authors used a network meta-analysis and evaluated study quality using the RoB 2 tool and CINeMA framework. Credible intervals (CrIs) were used to express uncertainty around the estimated treatment effects.
After treatment, all three types of CBT showed better outcomes compared to no treatment. Although ultra-complex CBT ranked highest in terms of effectiveness, followed by complex CBT and then core CBT, the differences between the CBT approaches were not clearly established at post-treatment. The authors also expressed the estimated effects in BDI points to make the reductions in depressive symptoms easier to interpret. SUCRA rankings placed ultra-complex CBT as the most likely to be the most effective option. At follow-up of 26 weeks or more, ultra-complex and complex CBT maintained statistically significant benefits compared with no treatment, whereas core CBT did not show a statistically significant long-term advantage. These results suggest that additional therapeutic components might help sustain progress after treatment ends.
Treatment effectiveness was influenced by both individual and contextual factors, as revealed by moderator analyses. Individuals with comorbid mental health problems appeared to benefit more from ultra-complex CBT, suggesting that additional structured interventions may be particularly useful in complex clinical presentations. The age of individuals influenced outcomes as well: younger adults responded best to ultra-complex CBT, whereas adults aged 31–59 benefited more from complex CBT. Both complex and ultra-complex CBT showed greater improvement in individuals from lower socioeconomic backgrounds, and ultra-complex CBT was effective even when delivered by non-mental health specialists. In contrast, core CBT delivered in a group format appeared relatively less effective, although this finding was based on a small number of studies and should be interpreted with caution.
The large number of randomized trials and participants included in the review provides a substantial evidence base. Additionally, it is the first review to categorize CBT specifically by complexity, providing new insight into how structural differences influence outcomes. Because many meta-analyses focus only on the immediate effects of treatment, long-term outcomes add considerable value. Furthermore, the use of rigorous methods such as RoB 2 and CINeMA strengthens the methodological approach, although the certainty of the findings varied across comparisons.
A few limitations exist, however. Considerable heterogeneity across studies, due to differences in participant characteristics, intervention formats, and treatment timelines, makes the findings more difficult to interpret. There was also evidence of publication bias, suggesting that studies with weaker or null results may have been underrepresented. It is difficult to determine how concurrent medication may have impacted outcomes because reporting of antidepressant use was inconsistent. Additionally, the wide differences in session length and treatment duration made it harder to directly compare the different CBT categories. Studies involving patients with comorbid personality disorders were also absent from the analysis.
Although there are some limitations, this study still provides useful takeaways for clinical practice. The findings challenge the idea that all CBT formats are equally effective in the long term and suggest that treatment complexity may matter. Ultra-complex CBT showed particularly promising long-term results, especially for those with comorbid mental health conditions. Complex CBT also demonstrated sustained benefits and may work well for many adult patients, while core CBT remains a valuable option, particularly for those without comorbid conditions. Overall, the results emphasize the importance of tailoring treatment structure to factors like age, comorbidity, socioeconomic background, and care setting, while also considering accessibility, staff availability, and costs.
The authors highlighted several key priorities for future research. They stressed the importance of clearer reporting on antidepressant use to better understand how medication works in combination with psychological therapy. More studies should include people with comorbid personality disorders, who were not represented in the included trials. Researchers should also specify exactly which CBT components are part of their interventions and examine patient factors that might affect treatment outcomes. Finally, further long-term follow-up studies would help clarify how well the benefits hold up over time.
Nincsenek megjegyzések:
Megjegyzés küldése